Sperimentazione clinica
Smart water bottles and coaching increased hydration but did not cut kidney stone recurrences, trial finds
Riportato dall'IA Immagine generata dall'IA Verificato
In a two-year U.S. trial of 1,658 adolescents and adults with prior kidney stones, a technology-assisted hydration program modestly increased urine output but did not significantly reduce symptomatic stone recurrences compared with standard care.
A one-year course of the drug abatacept can delay the onset of rheumatoid arthritis by up to four years in high-risk individuals. The benefits persisted long after treatment stopped, according to new research from King's College London.
Riportato dall'IA
A minimally invasive procedure called duodenal mucosal resurfacing may help patients maintain weight loss after discontinuing drugs like Ozempic and tirzepatide. Early results from the REMAIN-1 clinical trial show treated participants regained far less weight than those in a control group after six months off medication. The findings are set for presentation at Digestive Disease Week 2026.
L'ospedale provinciale clinico chirurgico Comandante Faustino Pérez ha avviato una sperimentazione clinica con il farmaco cubano Jusvinza per trattare la poliartrite residua nei sopravvissuti alla chikungunya. Lo studio valuta la capacità del farmaco di ridurre il dolore persistente e l'infiammazione articolare. Coinvolge 120 pazienti e mira a offrire un'opzione di trattamento accessibile.
Riportato dall'IA
Nella provincia cubana di Matanzas è iniziata una sperimentazione clinica per il farmaco Jusvinza, sviluppato dal Centro di Ingegneria Genetica e Biotecnologia (CIGB). Il medicinale è rivolto alla poliartrite residua nei pazienti in fase di recupero dal chikungunya. Questo passo rappresenta un progresso negli sforzi sanitari locali.
A Korean clinical trial has demonstrated that low-dose radiation therapy significantly reduces pain and improves mobility in patients with mild to moderate knee osteoarthritis, outperforming placebo effects. The treatment, which uses doses far below those for cancer, showed no side effects and could serve as an alternative to medications or surgery. Results were presented at the American Society for Radiation Oncology Annual Meeting.
Riportato dall'IA
A new topical serum containing plant extracts and growth proteins has shown promising results in increasing hair density and thickness within 56 days. Developed by researchers in Taiwan, the treatment outperformed a placebo in a small clinical trial involving 60 adults. While encouraging, experts call for larger studies to confirm its efficacy.